Vermillion, Inc.
(NASDAQ : VRML)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -0.53%62.861.0%$458.52m
AMGNAmgen, Inc. 0.18%240.921.3%$449.31m
BIIBBiogen, Inc. -0.30%285.271.4%$387.87m
ILMNIllumina, Inc. -0.20%325.333.5%$319.90m
VRTXVertex Pharmaceuticals, Inc. -0.63%234.011.9%$298.19m
REGNRegeneron Pharmaceuticals, Inc. -0.20%384.822.6%$229.42m
EXASEXACT Sciences Corp. -1.19%88.7124.0%$201.95m
ALXNAlexion Pharmaceuticals, Inc. 0.88%113.502.0%$195.59m
ITCIIntra-Cellular Therapies, Inc. -0.23%26.579.0%$175.40m
INCYIncyte Corp. -0.21%80.452.5%$149.05m
SRPTSarepta Therapeutics, Inc. -1.41%128.4714.6%$143.10m
ARWRArrowhead Pharmaceuticals, Inc. -1.03%56.5211.4%$132.09m
SGENSeattle Genetics, Inc. 0.86%108.596.1%$126.52m
BMRNBioMarin Pharmaceutical, Inc. -0.67%88.534.3%$108.54m
AAgilent Technologies, Inc. 0.69%90.081.6%$106.45m

Company Profile

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.